by newsworm | Apr 12, 2025 | Biocon, Pharma
Siddharth Mittal, CEO of Biocon Limited, has questioned the feasibility of shifting pharmaceutical manufacturing back to the US due to higher costs. At the Carnegie Global Technology Summit, he pointed out that Indian companies cannot afford to bring back... by newsworm | Apr 11, 2025 | Biocon, Pharma
Siddharth Mittal, CEO and Managing Director of Biocon Limited, expressed concerns about the feasibility of shifting pharmaceutical manufacturing from India and China to the US, due to the significant cost difference. He stated that if a drug is manufactured in China,... by newsworm | Apr 10, 2025 | Biocon, Pharma
Here is a summary of the content in 400 words: Biocon Biologics, the biosimilar arm of Biocon, has received approval from the US FDA for Jobevne, a cancer treatment drug. This is the company’s seventh biosimilar approved in the US and its fourth oncology... by newsworm | Apr 7, 2025 | Biocon, Pharma
The content excerpt appears to be incomplete, but based on the available information, here is a 400-word summary: Indian biotechnology major, Biocon Ltd, has announced plans to raise up to Rs 600 crore to fund its aggressive business growth plans. The company plans to... by newsworm | Apr 2, 2025 | Biocon, Pharma
Here is a 400-word summary of the content: Biocon’s CEO, Peter Bains, has resigned from his position. The news comes as a surprise, as Bains has led the company for nearly a decade, playing a significant role in its growth and success. His departure has left the... by newsworm | Mar 28, 2025 | Biocon, Pharma
Here is a 400-word summary of the content: Kiran Mazumdar-Shaw, the CEO of Biocon, took to social media to express her frustration with Bengaluru’s infrastructure. She compared the city’s streets to those in Ecuador, specifically San Cristobal Island, and...